Year :

Legend Biotech Announces ASH 2020 Data Presentations for Ciltacabtagene Autoleucel (cilta-cel), an Investigational BCMA CAR-T Cell Therapy in Development for Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM)

SOMERSET, N.J., November 5, 2020—Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, today announced that new and updated data from CARTITUDE-1 and LEGEND-2 studies, respectively, will be presented at the 62nd American Society of Hematology (ASH) […]

Nov 05, 2020

Legend Biotech to Participate in the Jefferies Virtual Cell Therapy Summit

SOMERSET, N.J.—(BUSINESS WIRE)—September 28, 2020—Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, will participate in the Jefferies Virtual Cell Therapy Summit on Tuesday, October 6th. Ying Huang, interim-Chief Executive Officer and Chief Financial Officer, will represent […]

Sep 28, 2020

Legend Biotech Names Current Chief Financial Officer, Ying Huang, as Interim CEO

September 21, 2020 – SOMERSET, N.J. – Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global, clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, today announced that its Board of Directors has appointed Dr. Ying Huang as interim Chief Executive Officer, effective immediately. Dr. Huang […]

Sep 21, 2020

Legend Biotech to Participate in the 18th Annual Morgan Stanley Virtual Global Healthcare Conference

SOMERSET, N.J.—(BUSINESS WIRE)—September 1, 2020—Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, will participate in the 18th Annual Morgan Stanley Virtual Global Healthcare Conference on Tuesday, September 15th. Frank Zhang, Chairman and Chief Executive Officer, and […]

Sep 01, 2020

Legend Biotech Reports Second Quarter 2020 Financial Results

SOMERSET, N.J.—(BUSINESS WIRE)—August 28, 2020—Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, today reported financial results for the quarter ended June 30, 2020. “Legend Biotech continues to execute on our corporate strategy, advancing the development of […]

Aug 28, 2020

Thank you for your interest in learning more about Legend Biotech.

Media Relations & Communications

media@legendbiotech.com

close

You are about to leave LegendBiotech.com

We use cookies to improve your experience on our website, measure performance, understand our audience, for advertising and support purposes. You can always change your preferences or opt out from our use of cookies.